Skip to main content
Veterinary Medicines

NOBILIS CAV P4 IM/SC

Suspended
  • Chicken anaemia virus, strain 26P4, Live

Product identification

Medicine name:
NOBILIS CAV P4 IM/SC
Active substance:
  • Chicken anaemia virus, strain 26P4, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Chicken anaemia virus, strain 26P4, Live
    10.00
    cell culture infective dose 50
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD04
Authorisation status:
  • Suspended
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3270 ESP
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 7/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 7/03/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 7/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."